Acute severe ulcerative colitis outcomes in patients treated with originator infliximab versus biosimilar infliximab

C. Gordon, L. Thin

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Fingerprint

Dive into the research topics of 'Acute severe ulcerative colitis outcomes in patients treated with originator infliximab versus biosimilar infliximab'. Together they form a unique fingerprint.

Medicine & Life Sciences